We are live on !
Find out more
Castleview Partners Portfolio holdings
AUM
$228M
Turnover
17.92%
1-Year Est. Return
13.32%
This Fund
S&P 500
This Quarter Est. Return
+1.49%
1 Year Est. Return
+13.32%
3 Year Est. Return
+61.28%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$228M
AUM Growth
+$665K
(+0.29%)
Cap. Flow
-$625K
Cap. Flow % of AUM
Cap. Flow %
-0.27%
Top 10 Holdings %
Top 10 Hldgs %
34.58%
Holding
240
New
17
Increased
117
Reduced
64
Closed
26
Avg Time Held
2.6
years
Top 10 Avg Time Held
1.6
years
Top 20 Avg Time Held
1.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Home Depot
HD
|
+$1.43M |
| 2 |
KKR & Co
KKR
|
+$1.33M |
| 3 |
VanEck Semiconductor ETF
SMH
|
+$1.19M |
| 4 |
Stryker
SYK
|
+$1.12M |
| 5 |
FT Vest Laddered Autocallable Barrier & Income ETF
ACYN
|
+$915K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nomura Tax-Free USA Short Term ETF
STAX
|
+$2.99M |
| 2 |
ProShares Ultra QQQ
QLD
|
+$1.57M |
| 3 |
Albertsons Companies
ACI
|
+$971K |
| 4 |
Regan Floating Rate MBS ETF
MBSF
|
+$946K |
| 5 |
ConocoPhillips
COP
|
+$901K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 53.03% |
| 2 | Healthcare | 10.3% |
| 3 | Financials | 7.67% |
| 4 | Technology | 7.28% |
| 5 | Consumer Discretionary | 7.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
126
VanEck CLO ETF
CLOI
$1.7B
| $444K | 0.19% |
8,376
-3,312
| -28% | -$175K |
2023 Q4
11 quarters
|
|
127
Vanguard FTSE Emerging Markets ETF
VWO
$120B
| $440K | 0.19% |
7,418
+1,707
| +30% | +$102K |
2026 Q2
1 quarter
|
|
128
Agnico Eagle Mines
AEM
$89.2B
| $438K | 0.19% |
2,391
+26
| +1% | +$4.61K |
2025 Q4
3 quarters
|
|
129
American Healthcare REIT
AHR
$11.6B
| $434K | 0.19% |
8,476
| – | – |
2024 Q3
8 quarters
|
|
130
Dynex Capital
DX
$2.74B
| $434K | 0.19% |
39,000
| – | – |
2025 Q4
3 quarters
|
|
131
Vanguard High Dividend Yield ETF
VYM
$82.8B
| $432K | 0.19% |
2,782
-2,831
| -50% | -$459K |
2026 Q1
2 quarters
|
|
132
JPMorgan US Momentum Factor ETF
JMOM
$2.65B
| $430K | 0.19% |
5,164
-10
| -0.2% | -$828 |
2025 Q2
5 quarters
|
|
133
iShares Systematic Alternatives Active ETF
IALT
$5.63B
| $426K | 0.19% |
14,276
+907
| +7% | +$26.3K |
2026 Q2
1 quarter
|
|
134
Illinois Tool Works
ITW
$79.5B
| $417K | 0.18% |
1,619
+230
| +17% | +$63.9K |
2025 Q4
3 quarters
|
|
135
Thermo Fisher Scientific
TMO
$250B
| $414K | 0.18% |
613
-45
| -7% | -$26.7K |
2018 Q1
34 quarters
|
|
136
State Street SPDR S&P Biotech ETF
XBI
$10.5B
| $409K | 0.18% |
2,594
+992
| +62% | +$157K |
2026 Q2
1 quarter
|
|
137
ASML
ASML
$601B
| $402K | 0.18% |
222
| – | – |
2026 Q1
2 quarters
|
|
138
FT Vest US Equity Deep Buffer ETF January
DJAN
$453M
| $397K | 0.17% |
8,506
| – | – |
2025 Q1
6 quarters
|
|
139
Entergy
ETR
$51.7B
| $390K | 0.17% |
3,927
+433
| +12% | +$46.7K |
2026 Q1
2 quarters
|
|
140
Colgate-Palmolive
CL
$77.6B
| $387K | 0.17% |
4,537
| – | – |
2026 Q1
2 quarters
|
|
141
Vanguard FTSE All-World ex-US ETF
VEU
$66.5B
| $378K | 0.17% |
4,559
+182
| +4% | +$15.3K |
2025 Q4
3 quarters
|
|
142
Vanguard Ultra-Short Bond ETF
VUSB
$9.9B
| $375K | 0.16% |
7,575
+126
| +2% | +$6.26K |
2025 Q1
6 quarters
|
|
143
Berkshire Hathaway Class B
BRK.B
$1.17T
| $371K | 0.16% |
745
+182
| +32% | +$91.8K |
2023 Q1
14 quarters
|
|
144
Fidelity MSCI Consumer Staples Index ETF
FSTA
$1.52B
| $370K | 0.16% |
7,268
+134
| +2% | +$7.13K |
2024 Q4
7 quarters
|
|
145
Invesco S&P 500 Momentum ETF
SPMO
$21.4B
| $358K | 0.16% |
2,360
-3,709
| -61% | -$552K |
2026 Q2
1 quarter
|
|
146
iShares U.S. Thematic Rotation Active ETF
THRO
$7.35B
| $357K | 0.16% |
8,107
+951
| +13% | +$41.3K |
2026 Q2
1 quarter
|
|
147
Moody's
MCO
$85B
| $351K | 0.15% |
773
-6
| -0.8% | -$2.91K |
2021 Q2
21 quarters
|
|
148
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$16.5B
| $346K | 0.15% |
6,694
-277
| -4% | -$14.4K |
2025 Q3
4 quarters
|
|
149
Fidelity AAA CLO ETF
FAAA
$85.6M
| $344K | 0.15% |
6,851
-2,562
| -27% | -$129K |
2026 Q2
1 quarter
|
|
150
Bluerock Private Real Estate Fund
BPRE
| $344K | 0.15% |
27,456
+2,516
| +10% | +$31.3K |
2026 Q1
2 quarters
|
|
Similar funds
MA
Castleview Partners's Q3 2026 Portfolio in Review
As of Q3 2026, Castleview Partners held 240 positions worth $228M, up 0.29% from $228M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Castleview Partners's Q3 2026 filing shows 17 new, 117 increased, 64 reduced and 26 closed positions. Its largest new stake was iShares 0-3 Month Treasury Bond ETF: 5,971 shares worth $601K. The largest sale was Nomura Tax-Free USA Short Term ETF, an estimated $2.99M.
By sector, the portfolio is most concentrated in Miscellaneous at 53% of assets, down from 53% a quarter earlier, followed by Healthcare and Financials.
- Castleview Partners's largest Q3 2026 buy was iShares 0-3 Month Treasury Bond ETF: 5,971 shares worth $601K.
- Castleview Partners added most to Home Depot in Q3 2026, an estimated $1.43M increase.
- Castleview Partners's biggest Q3 2026 reduction was Nomura Tax-Free USA Short Term ETF, cutting an estimated $2.99M.
- Castleview Partners fully exited Albertsons Companies in Q3 2026, selling an estimated $971K.
- Castleview Partners's ten largest holdings make up 35% of its $228M portfolio in Q3 2026.
- Castleview Partners opened 17 new positions and closed 26 in Q3 2026.
- Castleview Partners's portfolio value rose 0.29% quarter-over-quarter to $228M.
Based on Castleview Partners's 13F filing for Q3 2026, filed 9 Oct 2026.